TY  - JOUR 
AU  - Farrag, M.
AU  - Ait Eldjoudi, D.
AU  - González-Rodríguez, M.
AU  - Cordero Barreal, Alfonso
AU  - Ruiz Fernández, Clara
AU  - Capuozzo, M.
AU  - González-Gay Mantecón, Miguel Ángel
AU  - Mera, A.
AU  - Lago Paz, Francisca
AU  - Soffar, A.
AU  - Essawy, A.
AU  - Pino, J.
AU  - Farrag, Y.
AU  - Gualillo, Oreste
PY  - 2023
SN  - 1664-2392
UR  - http://hdl.handle.net/20.500.11940/21103
AB  - Adipose tissue malfunction leads to altered adipokine secretion which might consequently contribute to an array of metabolic diseases spectrum including obesity, diabetes mellitus, and cardiovascular disorders. Asprosin is a novel diabetogenic...
LA  - eng
KW  - Female
KW  - Humans
KW  - Diabetes Mellitus, Type 2
KW  - Peptide Hormones
KW  - Glucose
KW  - Obesity
KW  - Adipokines
TI  - Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
DO  - 10.3389/fendo.2022.1101091
T2  - Frontiers in Endocrinology
KW  - AS Santiago
KW  - IDIS
KW  - AS Santiago
KW  - IDIS
KW  - AS Santiago
KW  - CHUS
KW  - AS Santiago
KW  - CHUS
KW  - AS Santiago
KW  - CHUS
VL  - 13
ER  -